American regulator set to approve wider use of GSK's Arexvy

US Food and Drug Administration is due to authorise a respiratory virus vaccine for adults aged 50 to 59 in a boost to the British pharmaceuticals company

Related Keywords

United States ,Japan ,Delaware ,United Kingdom ,Britain ,America ,Americans ,Dame Emma Walmsley ,Drug Administration ,Pfizer ,American Big Pharma ,Emma Walmsley ,